AGENDA |
|
| 7:30 a.m. – 8:30 a.m. |
Registration and Continental Breakfast |
| |
|
Welcome |
| 8:30 a.m. – 8:40 a.m. |
NIDDK
Griffin P. Rodgers, M.D., M.A.C.P., Director, NIDDK |
| 8:40 a.m. – 8:50 a.m. |
National Institutes of Health (NIH)
Michael Gottesman, M.D. |
| 8:50 a.m. – 9:00 a.m. |
Foundation for Advanced Education in the Sciences (FAES)
Henry Metzger, M.D. |
| |
|
Scientific Program I |
| Session 1 Chair: Bruce Weintraub, M.D., Trophogen, Inc. |
| 9:00 a.m. – 9:30 a.m. |
Iodothyronine Deiodinases, Sonic Hedgehog, and Basal Cell Carcinoma
P. Reed Larsen, M.D., Brigham and Women’s Hospital and Harvard Medical School |
| 9:30 a.m. – 10:00 a.m. |
Molecular Mechanisms of Thyroid Carcinogenesis
Giancarlo Vecchio, M.D., University of Naples Federico II, Italy |
| 10:00 a.m. – 10:30 a.m. |
Thyroid Hormone Transport, Thyroid Hormone Receptors, and Thyroid Carcinogenesis
Sheue-Yann Cheng, Ph.D., National Cancer Institute |
| 10:30 a.m. – 11:00 a.m. |
Break |
| |
|
| Session 2 Chair: Jan Wolff, M.D., Ph.D., NIDDK |
| 11:00 a.m. – 11:30 a.m. |
From Compound X to Thyroid Hormone Action
Dr. Jamshed Tata, Ph.D., National Institute for Medical Research, United Kingdom |
| 11:30 a.m. – 12:00 p.m. |
Development/Evolution and Diseases: The Thyroid Gland Model
Roberto Di Lauro, M.D., Stazione Zoologica Anton Dohrn |
| 12:00 p.m. – 12:30 p.m. |
Low Molecular Weight Ligands for the Human TSH Receptor with Therapeutic Potential
Marvin Gershengorn, M.D., NIDDK |
| 12:30 p.m. – 2:00 p.m. |
Lunch Buffet (in foyer) |
| |
|
Scientific Program II |
| Session 3 Chair: Jesse Roth, M.D., F.A.C.P. |
| 2:00 p.m. – 2:30 p.m. |
Immunotoxins, Receptors, and CEB
Ira Pastan, M.D., National Cancer Institute |
| 2:30 p.m. – 3:00 p.m. |
Innate Immunity and the Toll-like Receptors
David Davies, Ph.D., NIDDK |
| 3:00 p.m. – 3:30 p.m. |
Break |
| |
|
| Session 4 Chair: Marshall Nirenberg, Ph.D., National Heart, Lung, and Blood Institute |
| 3:30 p.m. – 4:00 p.m. |
Tracking the Metabolic Syndrome to its Molecular Origins
C. Ronald Kahn, M.D., Joslin Diabetes Center and Harvard Medical School |
| 4:00 p.m. – 4:30 p.m. |
Endocrine Neoplasia, Leukemia, and Chromatin Modification: Bedside to Bench
Allen M. Spiegel, M.D., Albert Einstein College of Medicine |
| 4:30 p.m. – 5:00 p.m. |
Closing Remarks, Adjournment
Phillip Gorden, M.D., NIDDK |
| 6:30 p.m. |
Dinner at Tragara Restaurant (Bethesda, MD). All attendees are invited, cost is $50/person. |
| |
|
|
|
